Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants
NCT00056875
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Graft Versus Host Disease
Interventions
DRUG:
recombinant human keratinocyte growth factor
Sponsor
University of Michigan